There is a known inverse correlation between RKIP and CCL5 in breast cancer datasets, in addition to there being direct correlations between loss of RKIP and poor prognosis, and heightened CCL5 expression and poor prognosis. This evidence concerns the gene PEBP1 and breast carcinoma.